Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Valves01:16

Heart Valves

11.8K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
11.8K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

466
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
466
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

574
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
574
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

524
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
524
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

350
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
350
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

432
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
432

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and risk factors for permanent pacemaker implantation following aortic root surgery.

Open heart·2026
Same author

Commentary: Does early postoperative atrial fibrillation cost 6 months of life expectancy?

The Journal of thoracic and cardiovascular surgery·2026
Same author

Patient-centred anti-platelet therapy following coronary artery bypass graft surgery.

Journal of thrombosis and thrombolysis·2026
Same author

Patients' Experience With Enhanced Recovery After Cardiac Surgery.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Which Life Is More Important?

The Annals of thoracic surgery·2026
Same author

Long-term Survival and Stroke after Cardiac Surgery with Concomitant Surgical Ablation for Atrial Fibrillation.

Arrhythmia & electrophysiology review·2025

Related Experiment Video

Updated: Jan 28, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.6K

Sutureless aortic valve prostheses.

Rajdeep Bilkhu1, Michael A Borger2, Norman Paul Briffa3

  • 1Department of Cardiothoracic Surgery, St George's Hospital, London, UK.

Heart (British Cardiac Society)
|March 9, 2019
PubMed
Summary
This summary is machine-generated.

Sutureless aortic valve replacement (SU-AVR) offers reduced operative times for aortic valve stenosis treatment. While effective, it carries risks like paravalvular leak and pacemaker implantation, requiring careful consideration against conventional methods.

Keywords:
aortic stenosisprosthetic heart valvesvalve disease surgery

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.8K
Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

4.6K

Related Experiment Videos

Last Updated: Jan 28, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.6K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.8K
Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

4.6K

Area of Science:

  • Cardiovascular Surgery
  • Medical Devices
  • Interventional Cardiology

Background:

  • Severe aortic valve stenosis necessitates treatment, with conventional surgical aortic valve replacement (AVR) as the standard.
  • Increasing patient age and comorbidities drive demand for less invasive AVR techniques.
  • Sutureless aortic valves (SU-AVR) and transcatheter aortic valve implantation (TAVI) are emerging alternatives.

Purpose of the Study:

  • To review the current literature on sutureless aortic valve replacement (SU-AVR).
  • To compare SU-AVR with conventional AVR and TAVI.
  • To evaluate the benefits and risks associated with SU-AVR.

Main Methods:

  • Literature review of studies on SU-AVR, conventional AVR, and TAVI.
  • Analysis of operative times, patient outcomes, and complication rates.
  • Comparison of hemodynamic performance and long-term durability concerns.

Main Results:

  • SU-AVR and TAVI offer alternatives to conventional AVR, particularly for older or high-risk patients.
  • SU-AVR is associated with reduced operative times and potential hemodynamic benefits compared to conventional AVR.
  • TAVI shows superiority over medical therapy and non-inferiority to surgical AVR in specific patient groups, but with concerns regarding valve excision and complications like paravalvular leaks.

Conclusions:

  • SU-AVR minimizes suturing, reducing operative time and enabling valve explication, suitable for minimally invasive approaches and specific anatomies.
  • While SU-AVR offers advantages, increased risks of paravalvular leak and pacemaker implantation necessitate careful prosthesis selection.
  • The choice between SU-AVR, TAVI, and conventional AVR depends on individual patient factors, risk profiles, and desired outcomes.